Cel-Sci other research news

CELI presented research at the American Society of Microbiology meeting in New Orleans, showing that its heteroconjugate technology is able to induce a cellular immune response against a tuberculosis antigen. CELI's heteroconjugate includes two peptides, one from tuberculosis antigen and the other a synthetic peptide designed to prime the Th1 immune system pathway. ...